Read + Share
. Novel Intraprostatic Magnetic Resonance-Guided Implantation of Multidrug-Eluting
Microdevice for Testing of Systemic Therapy Agents In Situ: Proof of Concept in
Intermediate-Risk and High-Risk Prostate Cancer: Erratum. J Urol 2025;213:266.
PMID: 39783647
|
 |
|
